DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Funds / Frazier Life Sciences Viii, L.P.
Frazier Life Sciences Viii, L.P.
HarvestClosed to new capitalFundADV: Venture Capital FundFrazier Life Sciences Management, LPDelaware
Amounts, each with its basis
- Vintage
- 2015basis: form d first sale
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $262Mwhat may be sold, not what was raised; file 021-250272, sworn by the adviser or filed under this vehicle
- Form D sold
- $262Mas of the filing of Oct 29, 2015, 46 investors
- First sale
- Oct 15, 2015
- Reported GAV
- $161Mon the Form ADV filed Mar 30, 2024; the fund's assets, never its size or dry powder
- Owners (ADV)
- 45
- Reported on ADV
- Mar 31, 2022 to Mar 30, 2024
Fundraising evidence
Closed to new capital
Form D filed or amended 2015-10-29: the stated $262.0M offering reported fully sold (fr-1)
evidence dated Oct 29, 2015. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Harvest
vintage over 7 years, still reported
age years: 11first sale: 2015-10-15vintage year: $2,015adv gav as of: 2024-03-30vintage basis: form_d_first_saleform d sold usd: $262Mform d offering usd: $262Mform d latest filed at: 2015-10-29
The fund's own reporting through time
15 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 29, 2016 | Venture Capital Fund | $262M | 47 | $3.0M | 5% | yes | |
| May 6, 2016 | Venture Capital Fund | $262M | 47 | $3.0M | 5% | yes | |
| Jun 29, 2016 | Venture Capital Fund | $262M | 47 | $3.0M | 5% | yes | |
| Jun 29, 2016 | Venture Capital Fund | $262M | 47 | $3.0M | 5% | yes | |
| Mar 31, 2017 | Venture Capital Fund | $261M | 47 | $3.0M | 5% | yes | |
| May 17, 2017 | Venture Capital Fund | $261M | 47 | $3.0M | 5% | yes | |
| Mar 30, 2018 | Venture Capital Fund | $307M | 47 | $3.0M | 5% | yes | |
| Mar 29, 2019 | Venture Capital Fund | $287M | 47 | $3.0M | 5% | yes | |
| Mar 30, 2020 | Venture Capital Fund | $331M | 47 | $3.0M | 5% | yes | |
| Mar 31, 2021 | Venture Capital Fund | $544M | 46 | $3.0M | 5% | yes | |
| Nov 2, 2021 | Venture Capital Fund | $544M | 46 | $3.0M | 5% | yes | |
| Mar 31, 2022 | Venture Capital Fund | $372M | 46 | $3.0M | 5% | yes | |
| Mar 31, 2023 | Venture Capital Fund | $237M | 46 | $3.0M | 5% | yes | |
| Jan 12, 2024 | Venture Capital Fund | $237M | 46 | $3.0M | 5% | yes | |
| Mar 30, 2024 | Venture Capital Fund | $161M | 45 | $3.0M | 5% | yes |
Principals and agents
7 principals on Form D, 0 placement agents
- Nathan D. Every Promoter
- D. Frazier Management, L.L.C. Promoter
- Nader D. Naini Promoter
- Patrick J. Heron Executive Officer
- FHM Life Sciences VIII, L.L.C. Executive Officer
- James N. Topper Executive Officer
- Alan D. Frazier Promoter
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
3 events
- Mar 31, 2022Frazier Life Sciences Viii, L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reported Inference SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2016Frazier Life Sciences Viii, L.P. first reported on Form ADV by Frazier Healthcare (Venture Capital Fund), GAV $262,000,000Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Oct 29, 2015Frazier Life Sciences VIII, L.P. filed Form D: $262,000,000 sold of $262,000,000, Venture Capital FundForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this vehicle
- Entity type: Limited Partnership Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Form D fund type: Venture Capital Fund Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Pooled Investment Fund Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Not Applicable Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $262M Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $262M Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b, 3C, 3C.1, 3C.7 Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2015-10-15 Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 46 Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 68,750 Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: pooled Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 601 UNION STREET, SUITE 3200, SEATTLE, WA, 98101 Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2015 Oct 29, 2015 Fact SEC EDGAR Form D data sets (quarterly)